Symbotic Inc.
SYM · NASDAQ
Analyst ratings
hold · 9 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| May 26, 2026 | Goldman Sachs | Maintains | Sell | $45.00 |
| May 11, 2026 | DA Davidson | Maintains | Buy | $70.00 |
| April 15, 2026 | DA Davidson | Upgrades | Buy | $70.00 |
| March 16, 2026 | Barclays | Maintains | Underweight | $44.00 |
| February 9, 2026 | DA Davidson | Maintains | Neutral | $57.00 |
| February 5, 2026 | Needham | Maintains | Buy | $75.00 |
| January 12, 2026 | Barclays | Maintains | Underweight | $42.00 |
| December 2, 2025 | Goldman Sachs | Downgrades | Sell | $47.00 |
| November 26, 2025 | Baird | Maintains | Neutral | $58.00 |
| November 26, 2025 | Barclays | Maintains | Underweight | $41.00 |
| November 25, 2025 | Citigroup | Maintains | Buy | $70.00 |
| November 25, 2025 | DA Davidson | Maintains | Neutral | $47.00 |
| November 25, 2025 | Northland Capital Markets | Maintains | Outperform | $70.00 |
| November 25, 2025 | Cantor Fitzgerald | Maintains | Overweight | $82.00 |
| November 25, 2025 | Needham | Maintains | Buy | $70.00 |
| September 23, 2025 | UBS | Downgrades | Sell | $35.00 |
| August 25, 2025 | DA Davidson | Downgrades | Neutral | $47.00 |
Profitability and EPS performance vs. revenue growth trajectory
Revenue growth is undeniably strong, with Q2 FY2026 hitting $676M (beating estimates by 2.09%), systems revenue up 24% YoY, software revenue surging 93%, and adjusted EBITDA doubling to $78M. Management projects FY2026 revenue of $2.79B and FY2027 of $3.57B, signaling a credible path to profitability.
Despite revenue beats, EPS of $0.01 missed the $0.12 forecast by a stark 91.67%, and the company carries a negative net margin of -0.20% and negative return on equity of -0.68%. Barclays and Goldman Sachs both maintain sell ratings, reflecting deep skepticism about near-term earnings power.
Analyst price target divergence and valuation disagreement
A majority of analysts — 10 buys vs. 3 sells among 19 covering the stock — see significant upside, with an average 12-month price target of $65.67, representing over 59% upside. Oppenheimer targets $84 and Craig-Hallum targets $80, arguing Symbotic remains undervalued relative to its warehouse automation growth narrative.
Goldman Sachs cut its target from $54 to $45 with a sell rating, Barclays rates it underweight at $44, and Weiss Ratings downgraded to sell. The stock is trading near its 52-week low of $38.19, far below the $87.88 high, reflecting that the market has repriced growth expectations sharply downward.
Insider selling activity and near-term confidence signals
Symbotic maintains a robust $22.7B backlog, providing strong revenue visibility well into the future. With 61% buy ratings among analysts and Q3 FY2026 revenue guidance of $700M–$720M, institutional support and forward momentum suggest the company's long-term growth story remains intact despite short-term noise.
A series of insider sales by director Krasnow across May, June, and July 2026, including a $87,840 transaction, may signal limited near-term confidence from those closest to the company. Combined with mixed quarterly results and a stock price near the lower end of its 52-week range, these moves add to investor unease.